nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP2D6—Parkinson's disease	0.457	0.583	CbGaD
Temsirolimus—ABCB1—Parkinson's disease	0.326	0.417	CbGaD
Temsirolimus—MTOR—forelimb—Parkinson's disease	0.00959	0.192	CbGeAlD
Temsirolimus—MTOR—hindbrain—Parkinson's disease	0.00393	0.0787	CbGeAlD
Temsirolimus—MTOR—embryo—Parkinson's disease	0.00246	0.0492	CbGeAlD
Temsirolimus—MTOR—brainstem—Parkinson's disease	0.00225	0.0451	CbGeAlD
Temsirolimus—MTOR—forebrain—Parkinson's disease	0.00217	0.0435	CbGeAlD
Temsirolimus—FKBP1A—forebrain—Parkinson's disease	0.00196	0.0392	CbGeAlD
Temsirolimus—MTOR—cardiovascular system—Parkinson's disease	0.00184	0.0368	CbGeAlD
Temsirolimus—FKBP1A—cardiovascular system—Parkinson's disease	0.00165	0.0331	CbGeAlD
Temsirolimus—FKBP1A—medulla oblongata—Parkinson's disease	0.00141	0.0283	CbGeAlD
Temsirolimus—MTOR—spinal cord—Parkinson's disease	0.0014	0.028	CbGeAlD
Temsirolimus—FKBP1A—midbrain—Parkinson's disease	0.00129	0.0259	CbGeAlD
Temsirolimus—FKBP1A—spinal cord—Parkinson's disease	0.00126	0.0252	CbGeAlD
Temsirolimus—MTOR—head—Parkinson's disease	0.00124	0.0249	CbGeAlD
Temsirolimus—MTOR—nervous system—Parkinson's disease	0.00118	0.0236	CbGeAlD
Temsirolimus—CYP2D6—hindbrain—Parkinson's disease	0.00114	0.0228	CbGeAlD
Temsirolimus—MTOR—central nervous system—Parkinson's disease	0.00114	0.0228	CbGeAlD
Temsirolimus—FKBP1A—head—Parkinson's disease	0.00112	0.0224	CbGeAlD
Temsirolimus—MTOR—cerebellum—Parkinson's disease	0.00111	0.0222	CbGeAlD
Temsirolimus—FKBP1A—nervous system—Parkinson's disease	0.00106	0.0213	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—Parkinson's disease	0.00102	0.0205	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—Parkinson's disease	0.000999	0.02	CbGeAlD
Temsirolimus—MTOR—brain—Parkinson's disease	0.000902	0.0181	CbGeAlD
Temsirolimus—FKBP1A—brain—Parkinson's disease	0.000811	0.0162	CbGeAlD
Temsirolimus—CYP2D6—brainstem—Parkinson's disease	0.000651	0.013	CbGeAlD
Temsirolimus—CYP2D6—forebrain—Parkinson's disease	0.000629	0.0126	CbGeAlD
Temsirolimus—Sirolimus—ABCB1—Parkinson's disease	0.000554	0.5	CrCbGaD
Temsirolimus—Tacrolimus—ABCB1—Parkinson's disease	0.000554	0.5	CrCbGaD
Temsirolimus—ABCB1—embryo—Parkinson's disease	0.000511	0.0102	CbGeAlD
Temsirolimus—ABCB1—forebrain—Parkinson's disease	0.000452	0.00906	CbGeAlD
Temsirolimus—ABCB1—cardiovascular system—Parkinson's disease	0.000382	0.00766	CbGeAlD
Temsirolimus—CYP2D6—head—Parkinson's disease	0.00036	0.00721	CbGeAlD
Temsirolimus—CYP3A4—nervous system—Parkinson's disease	0.000347	0.00695	CbGeAlD
Temsirolimus—CYP2D6—nervous system—Parkinson's disease	0.000341	0.00684	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—Parkinson's disease	0.000334	0.00669	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—Parkinson's disease	0.000329	0.00658	CbGeAlD
Temsirolimus—ABCB1—medulla oblongata—Parkinson's disease	0.000327	0.00654	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—Parkinson's disease	0.000321	0.00643	CbGeAlD
Temsirolimus—ABCB1—midbrain—Parkinson's disease	0.000299	0.00598	CbGeAlD
Temsirolimus—ABCB1—spinal cord—Parkinson's disease	0.000291	0.00584	CbGeAlD
Temsirolimus—CYP2D6—brain—Parkinson's disease	0.000261	0.00523	CbGeAlD
Temsirolimus—ABCB1—head—Parkinson's disease	0.000259	0.00519	CbGeAlD
Temsirolimus—ABCB1—nervous system—Parkinson's disease	0.000246	0.00492	CbGeAlD
Temsirolimus—ABCB1—central nervous system—Parkinson's disease	0.000236	0.00473	CbGeAlD
Temsirolimus—ABCB1—cerebellum—Parkinson's disease	0.000231	0.00463	CbGeAlD
Temsirolimus—ABCB1—brain—Parkinson's disease	0.000188	0.00376	CbGeAlD
Temsirolimus—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	7.58e-05	0.000456	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.49e-05	0.000451	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.33e-05	0.000441	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MCCC1—Parkinson's disease	7.31e-05	0.00044	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ND3—Parkinson's disease	7.31e-05	0.00044	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—INSR—Parkinson's disease	7.3e-05	0.000439	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ABL1—Parkinson's disease	7.29e-05	0.000439	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GRK5—Parkinson's disease	7.23e-05	0.000435	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.23e-05	0.000435	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PARK2—Parkinson's disease	7.15e-05	0.00043	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGF20—Parkinson's disease	7.09e-05	0.000427	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RPL14—Parkinson's disease	7.02e-05	0.000423	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RPL23A—Parkinson's disease	7.02e-05	0.000423	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.91e-05	0.000416	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGB—Parkinson's disease	6.9e-05	0.000415	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TALDO1—Parkinson's disease	6.87e-05	0.000413	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—OMD—Parkinson's disease	6.87e-05	0.000413	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR1A—Parkinson's disease	6.86e-05	0.000413	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.82e-05	0.00041	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TAC1—Parkinson's disease	6.76e-05	0.000407	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.65e-05	0.0004	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD1—Parkinson's disease	6.62e-05	0.000399	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RPS8—Parkinson's disease	6.55e-05	0.000394	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGF20—Parkinson's disease	6.55e-05	0.000394	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	6.51e-05	0.000392	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—Parkinson's disease	6.5e-05	0.000391	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GRM4—Parkinson's disease	6.49e-05	0.00039	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD3—Parkinson's disease	6.42e-05	0.000386	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.32e-05	0.00038	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CASP3—Parkinson's disease	6.29e-05	0.000379	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.23e-05	0.000375	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—Parkinson's disease	6.22e-05	0.000374	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GCH1—Parkinson's disease	6.21e-05	0.000374	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—MAPK8—Parkinson's disease	6.17e-05	0.000371	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PENK—Parkinson's disease	6.15e-05	0.00037	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAG—Parkinson's disease	6.15e-05	0.00037	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—Parkinson's disease	6.12e-05	0.000369	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRBK1—Parkinson's disease	5.99e-05	0.000361	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—Parkinson's disease	5.85e-05	0.000352	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—Parkinson's disease	5.82e-05	0.00035	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD2—Parkinson's disease	5.8e-05	0.000349	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR7—Parkinson's disease	5.8e-05	0.000349	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MTHFR—Parkinson's disease	5.8e-05	0.000349	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—Parkinson's disease	5.79e-05	0.000348	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—MAPK8—Parkinson's disease	5.78e-05	0.000348	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—Parkinson's disease	5.76e-05	0.000347	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PDYN—Parkinson's disease	5.62e-05	0.000338	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—DDC—Parkinson's disease	5.62e-05	0.000338	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.57e-05	0.000335	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GBA—Parkinson's disease	5.54e-05	0.000333	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—FBP1—Parkinson's disease	5.54e-05	0.000333	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DBH—Parkinson's disease	5.54e-05	0.000333	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.51e-05	0.000332	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ND3—Parkinson's disease	5.51e-05	0.000332	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.51e-05	0.000332	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	5.42e-05	0.000326	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—Parkinson's disease	5.42e-05	0.000326	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—Parkinson's disease	5.42e-05	0.000326	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APOE—Parkinson's disease	5.4e-05	0.000325	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—Parkinson's disease	5.37e-05	0.000323	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—Parkinson's disease	5.33e-05	0.00032	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTA4—Parkinson's disease	5.31e-05	0.00032	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—Parkinson's disease	5.3e-05	0.000319	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GFAP—Parkinson's disease	5.29e-05	0.000318	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.24e-05	0.000315	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GRM5—Parkinson's disease	5.23e-05	0.000315	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.21e-05	0.000314	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ADRBK1—Parkinson's disease	5.21e-05	0.000314	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.2e-05	0.000313	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ND3—Parkinson's disease	5.19e-05	0.000313	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.19e-05	0.000313	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.18e-05	0.000312	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—OMD—Parkinson's disease	5.18e-05	0.000312	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.17e-05	0.000311	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.14e-05	0.000309	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.12e-05	0.000308	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.91e-05	0.000296	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.88e-05	0.000294	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—OMD—Parkinson's disease	4.88e-05	0.000294	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF2—Parkinson's disease	4.86e-05	0.000293	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ADRBK1—Parkinson's disease	4.81e-05	0.00029	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	4.8e-05	0.000289	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.79e-05	0.000288	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	4.78e-05	0.000288	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HSPA1A—Parkinson's disease	4.78e-05	0.000287	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MAOB—Parkinson's disease	4.73e-05	0.000285	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.72e-05	0.000284	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF1R—Parkinson's disease	4.7e-05	0.000283	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCH1—Parkinson's disease	4.69e-05	0.000282	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EDN1—Parkinson's disease	4.65e-05	0.00028	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.63e-05	0.000279	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—INS—Parkinson's disease	4.61e-05	0.000277	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF20—Parkinson's disease	4.59e-05	0.000276	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADORA2A—Parkinson's disease	4.45e-05	0.000268	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.42e-05	0.000266	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NGF—Parkinson's disease	4.27e-05	0.000257	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ABL1—Parkinson's disease	4.25e-05	0.000256	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GBA—Parkinson's disease	4.18e-05	0.000251	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—FBP1—Parkinson's disease	4.18e-05	0.000251	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DBH—Parkinson's disease	4.18e-05	0.000251	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—INSR—Parkinson's disease	4.1e-05	0.000247	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR2A—Parkinson's disease	4.06e-05	0.000245	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—DDC—Parkinson's disease	4.06e-05	0.000245	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HGF—Parkinson's disease	3.99e-05	0.00024	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—Parkinson's disease	3.94e-05	0.000237	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DBH—Parkinson's disease	3.94e-05	0.000237	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.94e-05	0.000237	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GBA—Parkinson's disease	3.94e-05	0.000237	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGB—Parkinson's disease	3.88e-05	0.000233	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR1A—Parkinson's disease	3.86e-05	0.000232	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTA4—Parkinson's disease	3.84e-05	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TAC1—Parkinson's disease	3.8e-05	0.000229	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APOE—Parkinson's disease	3.78e-05	0.000227	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.74e-05	0.000225	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD1—Parkinson's disease	3.73e-05	0.000224	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—Parkinson's disease	3.69e-05	0.000222	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.65e-05	0.00022	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD3—Parkinson's disease	3.61e-05	0.000217	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	3.52e-05	0.000212	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.5e-05	0.000211	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	3.46e-05	0.000208	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CTGF—Parkinson's disease	3.45e-05	0.000208	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.44e-05	0.000207	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MAOB—Parkinson's disease	3.42e-05	0.000206	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.4e-05	0.000204	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ND3—Parkinson's disease	3.4e-05	0.000204	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRBK1—Parkinson's disease	3.37e-05	0.000203	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAPK8—Parkinson's disease	3.3e-05	0.000199	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR7—Parkinson's disease	3.26e-05	0.000196	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD2—Parkinson's disease	3.26e-05	0.000196	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MTHFR—Parkinson's disease	3.26e-05	0.000196	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—INS—Parkinson's disease	3.23e-05	0.000194	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	3.22e-05	0.000194	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—OMD—Parkinson's disease	3.19e-05	0.000192	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.19e-05	0.000192	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NQO1—Parkinson's disease	3.18e-05	0.000191	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TH—Parkinson's disease	3.13e-05	0.000189	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—DDC—Parkinson's disease	3.07e-05	0.000185	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.05e-05	0.000183	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOE—Parkinson's disease	3.03e-05	0.000183	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.03e-05	0.000182	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYCS—Parkinson's disease	3.01e-05	0.000181	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.9e-05	0.000174	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—DDC—Parkinson's disease	2.89e-05	0.000174	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.89e-05	0.000174	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF2—Parkinson's disease	2.73e-05	0.000165	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.73e-05	0.000164	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.72e-05	0.000164	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—COMT—Parkinson's disease	2.67e-05	0.00016	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTP1—Parkinson's disease	2.65e-05	0.00016	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MAOA—Parkinson's disease	2.65e-05	0.000159	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1R—Parkinson's disease	2.64e-05	0.000159	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HMOX1—Parkinson's disease	2.62e-05	0.000157	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EDN1—Parkinson's disease	2.61e-05	0.000157	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.000157	CbGpPWpGaD
Temsirolimus—MTOR—Disease—INS—Parkinson's disease	2.59e-05	0.000156	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MAOB—Parkinson's disease	2.58e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.57e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DBH—Parkinson's disease	2.57e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GBA—Parkinson's disease	2.57e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.54e-05	0.000153	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCB1—Parkinson's disease	2.51e-05	0.000151	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.5e-05	0.00015	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.46e-05	0.000148	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2.44e-05	0.000147	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.43e-05	0.000146	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—Parkinson's disease	2.4e-05	0.000145	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NGF—Parkinson's disease	2.4e-05	0.000144	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GPX1—Parkinson's disease	2.33e-05	0.00014	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	2.33e-05	0.00014	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NQO1—Parkinson's disease	2.3e-05	0.000138	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2A—Parkinson's disease	2.29e-05	0.000138	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TH—Parkinson's disease	2.27e-05	0.000136	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK8—Parkinson's disease	2.21e-05	0.000133	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.18e-05	0.000131	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.15e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—Parkinson's disease	2.12e-05	0.000128	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—Parkinson's disease	2.11e-05	0.000127	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—Parkinson's disease	2.1e-05	0.000126	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—Parkinson's disease	2.01e-05	0.000121	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—Parkinson's disease	2.01e-05	0.000121	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—COMT—Parkinson's disease	1.93e-05	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK8—Parkinson's disease	1.92e-05	0.000116	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.92e-05	0.000115	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.92e-05	0.000115	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.91e-05	0.000115	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.89e-05	0.000114	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—DDC—Parkinson's disease	1.89e-05	0.000114	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CTGF—Parkinson's disease	1.88e-05	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—INS—Parkinson's disease	1.82e-05	0.000109	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.82e-05	0.000109	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.78e-05	0.000107	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.77e-05	0.000107	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.76e-05	0.000106	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NQO1—Parkinson's disease	1.73e-05	0.000104	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—INS—Parkinson's disease	1.71e-05	0.000103	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TH—Parkinson's disease	1.71e-05	0.000103	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.69e-05	0.000102	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.65e-05	9.95e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYCS—Parkinson's disease	1.64e-05	9.88e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.63e-05	9.84e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TH—Parkinson's disease	1.61e-05	9.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.61e-05	9.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.59e-05	9.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.56e-05	9.37e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.55e-05	9.31e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—COMT—Parkinson's disease	1.45e-05	8.75e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—Parkinson's disease	1.45e-05	8.73e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.45e-05	8.71e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MAOA—Parkinson's disease	1.44e-05	8.69e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.43e-05	8.59e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—Parkinson's disease	1.41e-05	8.49e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—COMT—Parkinson's disease	1.37e-05	8.24e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.36e-05	8.21e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.36e-05	8.19e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—Parkinson's disease	1.35e-05	8.13e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.34e-05	8.09e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.33e-05	8e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.29e-05	7.77e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX1—Parkinson's disease	1.27e-05	7.66e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.25e-05	7.54e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK8—Parkinson's disease	1.24e-05	7.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—INS—Parkinson's disease	1.24e-05	7.45e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—Parkinson's disease	1.23e-05	7.38e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.2e-05	7.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.18e-05	7.11e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.18e-05	7.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.16e-05	6.98e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—Parkinson's disease	1.13e-05	6.82e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.11e-05	6.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—Parkinson's disease	1.09e-05	6.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.08e-05	6.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.07e-05	6.43e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TH—Parkinson's disease	1.05e-05	6.34e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—Parkinson's disease	1.03e-05	6.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.01e-05	6.09e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—INS—Parkinson's disease	9.35e-06	5.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—COMT—Parkinson's disease	8.96e-06	5.39e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.91e-06	5.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.89e-06	5.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—INS—Parkinson's disease	8.81e-06	5.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.79e-06	5.29e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.44e-06	5.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.19e-06	4.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—Parkinson's disease	7.93e-06	4.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.85e-06	4.72e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.24e-06	4.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—Parkinson's disease	6.74e-06	4.06e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—INS—Parkinson's disease	5.76e-06	3.47e-05	CbGpPWpGaD
